Resumen

Mexico has seen an increase in cancer prevalence in its entire population as well as particular age ranges, predominantly the older segment. The most frequently reported pelvic cancers in Mexico are cervical, endometrial, bladder, prostate, rectum, and anal canal. Approximately 80% of the population diagnosed with pelvic cancers present with locally advanced tumors and require concomitant chemoradiotherapy, sequential chemoradiotherapy, or radiotherapy alone. The toxicity of any of these treatment modalities may be manifested as intestinal injury, a significant problem that can compromise the response to treatment, the patient’s nutritional state, quality of life, and survival. In this article, we will approach key aspects in nutrition as well as the epidemiological characteristics and toxicities in patients affected by these pelvic tumors.

Palabras clave: Epidemiology pelvic cancer radiotherapy chemotherapy gastrointestinal toxicity.

2018-08-24   |   320 visitas   |   Evalua este artículo 0 valoraciones

Vol. 70 Núm.3. Mayo-Junio 2018 Pags. 112-116 Rev Invest Clin 2018; 70(3)